Sangoma Technologies Bolsa (NASDAQ: SANG)

Últimas noticias sobre Sangoma Technologies (NASDAQ:SANG) Bolsa

Sangoma Technologies

Sangoma Technologies Corp is a provider of hardware and software components that enable or enhance Internet Protocol Communications Systems for both telecom and datacom applications. It is engaged in the development, manufacturing, distribution, and support of voice and data connectivity components for software-based communication applications. Its product includes data and telecom boards for media and signal processing, as well as gateway appliances and software. The Company sells into two geographic centers: USA and Other countries. Key revenue is generated from USA.

Analyst Color

Earnings

Equities

News

Futures

Economics

Pre-Market Outlook

Markets

Analyst Ratings

AMZN

FTNT

NVDA

RANI

RBLX

SANG

Las acciones de EE.UU. suben mientras los inversores analizan los aranceles, resultados financieros y expectativas de la Fed.

Los futuros de Wall Street suben: ¿Cómo impactarán los aranceles y las ganancias empresariales?

Movers

Trading Ideas

AEON

ANIP

BBAI

BLRX

CFFI

DOYU

GCTK

LUXH

PMAX

QUBT

RIME

SIBN

SLXN

SOBR

SONM

TNXP

WHLR

TSMC y otras acciones destacaron en el premercado tras reportar ganancias récord. Descubre los mayores ganadores y perdedores.

Acciones de Taiwan Semiconductor (TSM) suben alrededor del 5%; 20 acciones en movimiento en el premercado de EE.UU.

AEHR

ATCH

ATPC

AVGR

CANG

CHCI

HCWC

LIDR

NMHI

PHIO

PIII

RGNX

STAF

URGN

YOSH

Las acciones de KB Home suben 9,1% tras superar expectativas de ganancias. Descubre los mayores ganadores y perdedores del mercado hoy.

Las acciones de KB Home se disparan un 9%; 20 acciones que se mueven en el premercado de EE.UU.

Sangoma Technologies Corporation - Common Shares

Sangoma Technologies Corp

Sangamo Therapeutics, Inc. - Common Stock

Sangamo Therapeutics Inc

Sangetsu Corp

SANGUI BIOTECH INTL INC by Sangui BioTech International, Inc.

Sangui Biotech International Inc

Saia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAIA#NASDAQ">SAIA</a>) has outperformed the market over the past 15 years by 12.18% on an annualized basis producing an average annual return of 24.09%. Currently, Saia has a market capitalization of $6.75 billion. 
Buying $100 In SAIA: If an investor had bought $100 of SAIA stock 15 years ago, it would be worth $2,597.71 today based on a price of $253.45 for SAIA at the time of writing.
<h3>Saia's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749159917_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

SAIA

Here's How Much You Would Have Made Owning Saia Stock In The Last 15 Years

General

HWBK

Hawthorn Bancshares Authorize The Repurchase Of Up To $10.0M  In Market Value Of The Company's Common Stock

Petco Health and Wellness Company, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) released its first-quarter results after Thursday's closing bell. Here's a look at the <a href="https://www.benzinga.com/pressreleases/25/06/n45802282/petco-health-wellness-company-inc-reports-first-quarter-2025-financial-results">details in the report. </a>
The Details: Petco Health and Wellness reported quarterly losses of four cents per share, which met the analyst consensus estimate. Quarterly revenue came in at $1.49 billion, missing the Street estimate of $1.5 billion and down from revenue of $1.53 billion from the same period last year.
Read Next:<a href="https://www.benzinga.com/markets/market-summary/25/06/45798808/trump-announces-china-trade-talks-tesla-stock-slumps-whats-driving-markets-thursday?utm_source=articleShare"> Trump Announces China Trade Talks, Tesla Stock Slumps: What&#8217;s Driving Markets Thursday?</a>
Petco reported: 
<ul class="wp-block-list">
<li>Net sales of $1.5 billion decreased 2.3% year-over-year in line with the company&#8217;s first quarter outlook.</li>
<li>Comparable sales decreased 1.3% year-over-year.</li>
<li>Gross profit margin expanded approximately 30 basis points to 38.2% as a percentage of net sales.</li>
</ul>
&#8220;We are pleased to deliver first quarter earnings results ahead of our guidance and to reaffirm our outlook for fiscal 2025, which now incorporates the impact of tariffs. This performance is a testament to the execution of our nearly 30,000 team members and the resilience of the category in which we operate,&#8221; said Joel Anderson, Petco&#8217;s CEO.
WOOF Price Action: According to data from<a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw"> Benzinga Pro</a>, Petco stock was down 10.77% at $3.23 at publication during Thursday's extended trading. 
Read Next:&nbsp;
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/social-media/25/06/45749596/the-viral-student-loan-solution-people-cant-stop-talking-about?utm_source=articleShare">Elon Musk&#8217;s Optimus Could Herald The Biggest Industry In History, Billionaire Investor Marc Andreessen Says</a></li>
</ul>
Photo: Shutterstock

After-Hours Center

WOOF

Petco Stock Drops After Q1 Revenues Miss: Details

Sekisui House (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SKHSY#OTC">SKHSY</a>) GAAP EPS for Q1 2025 JPY 51.48 Down from JPY 77.80 YoY; Revenue JPY 894,044M Up from 777,052M YoY.

Earnings Misses

SKHSY

Sekisui House GAAP EPS for Q1 2025 JPY 51.48 Down from JPY 77.80 YoY; Revenue JPY 894,044M Up from 777,052M YoY.

Kadant (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KAI#NYSE">KAI</a>) has outperformed the market over the past 5 years by 10.79% on an annualized basis producing an average annual return of 23.86%. Currently, Kadant has a market capitalization of $3.81 billion. 
Buying $1000 In KAI: If an investor had bought $1000 of KAI stock 5 years ago, it would be worth $2,858.22 today based on a price of $323.55 for KAI at the time of writing.
<h3>Kadant's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749159021_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning Kadant Stock In The Last 5 Years

ENTO

Entero Therapeutics Now Offering 15.2M Shares Of Common Stock

OCTO

Eightco Holdings Enters Settlement Agreements With Third Parties, Including CFO And Board Member; Liabilities Reduced From Over $2.2M To About $1.1M Under Settlement

PJT Partners (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PJT#NYSE">PJT</a>) has outperformed the market over the past 5 years by 8.85% on an annualized basis producing an average annual return of 21.93%. Currently, PJT Partners has a market capitalization of $3.70 billion. 
Buying $1000 In PJT: If an investor had bought $1000 of PJT stock 5 years ago, it would be worth $2,675.52 today based on a price of $151.06 for PJT at the time of writing.
<h3>PJT Partners's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749158110_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning PJT Partners Stock In The Last 5 Years

GlobeNewswire Issues Report Saying "We Are Advised By ZJK Industrial Co., Ltd. That Journalists And Other Readers Should Disregard The News Release, "ZJK Industrial Co., Ltd. Ramps Up Production To Support Nvidia's B40 Project, Expecting Significant YoY Revenue Growth" Issued On June 5, 2025 At 08:00 am EDT"

<a href="https://www.benzinga.com/etfs">Exchange-traded funds</a> with significant exposure to Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) could be in for a rough ride, not due to production setbacks or margin squeeze, but thanks to a new set of political fireworks between <a href="https://www.benzinga.com/news/politics/25/06/45800612/trump-says-musk-has-trump-derangement-syndrome-as-battle-over-bill-heats-up-had-a-great-relationship-dont-know-if-we-will-anymore">Elon Musk and Donald Trump</a>.
On Tuesday, <a href="https://www.benzinga.com/trading-ideas/movers/25/06/45795638/tesla-stock-slumps-amid-political-turmoil-whats-going-on">TSLA stock plummeted</a> as President Trump publicly criticized Musk, stating he was &#8220;disappointed&#8221; with the Tesla CEO&#8217;s &#8220;furious bashing&#8221; of the tax legislation. The remark came on the heels of reports that Musk, in behind-the-scenes talks, showed intense opposition to the bill&#8217;s incentives for clean energy, which he feels benefit union-supported automakers at Tesla&#8217;s expense. On Thursday, the Tesla stock is down a sharp 15%.
While Musk has never hesitated to court controversy, the new spat adds one more level of risk for investors, especially those who are exposed through ETFs that hold Tesla as a strategic holding.
Also Read: <a href="https://www.benzinga.com/news/politics/25/06/45795080/whatever-you-think-of-elon-musk-you-must-support-his-fight-against-the-big-beautiful-bill-says-black-swan-author-nassim-taleb">&#8216;Whatever You Think Of Elon Musk, You Must Support His Fight Against The Big Beautiful Bill,&#8217; Says &#8216;Black Swan&#8217; Author Nassim Taleb</a>
<h2 class="wp-block-heading">ETFs In The Crosshairs</h2>
Tesla is still a major contributor to a number of actively and passively managed ETFs, particularly those that concentrate on innovation, EVs, and clean energy. Some of the most exposed:
ARK Innovation ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKK#BATS">ARKK</a>) – Tesla is the single largest holding, frequently making up 12% or more of the portfolio.
iShares Self-Driving EV and Tech ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IDRV#NYSE">IDRV</a>) – Tesla is frequently in the top five, but it has cut its weightage to 3.5% in the last rejig.
KraneShares Electric Vehicles and Future Mobility ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KARS#NYSE">KARS</a>) – TSLA is prominent, at almost 4% weightage.
They&#8217;ve gone through volatility already with Tesla&#8217;s stock price, which fell almost 20% through the past five trading days. But political tension adds a wilder variable, one that&#8217;s difficult to price into models and more difficult to hedge in a diversified basket.
<h2 class="wp-block-heading">Passive Exposure, Active Headaches</h2>
For individual investors who are not monitoring every political headline, indirect exposure to these risks through ETFs can be a surprise in store.
This is the classic example of political risk spilling over into passive portfolios. When Tesla catches a cold, ARKK gets it, and when Musk gets involved in a political fight, it&#8217;s the ETF investors who will need a flu shot.
<h2 class="wp-block-heading">Looking Ahead</h2>
In the near term, ETF issuers won&#8217;t rebalance on political noise alone. But ongoing stress about Tesla&#8217;s regulatory and political positioning might impact flows.
For investors in ETFs, the takeaway can be less about Musk himself and more learning what&#8217;s driving their portfolios from beneath the hood. Because sometimes, earnings or interest rates aren&#8217;t driving your fund, it&#8217;s Elon Musk, a tweet from some social media account, and a news headline with Donald Trump&#8217;s name on it.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/etfs/new-etfs/25/06/45801050/crash-proof-investing-new-innovator-etf-promises-downside-buffer">Crash-Proof Investing? New Innovator ETF Promises Downside Buffer</a></li>
</ul>
Photo: Shutterstock

Specialty ETFs

Tech

ETFs

ARKK

IDRV

KARS

TSLA

Trump-Musk Feud Gets Ugly: ETFs Exposed With Tesla Caught In The Crossfire

Offerings

Trump Media & Technology Files For Primary Mixed Shelf Offering Of Up To $12B

Xtract One Technologies (TSX:<a class="ticker" href="https://www.benzinga.com/stock/XTRA#TSX">XTRA</a>) reported quarterly losses of $(0.02) per share. This is a 100 percent decrease over losses of $(0.01) per share from the same period last year. The company reported $3.47 million in sales this quarter. This is a 26.00 percent decrease over sales of $4.68 million the same period last year.

TSX:XTRA

Xtract One Technologies Q3 EPS $(0.02) Down From $(0.01) YoY, Sales $3.47M Down From $4.68M YoY

Trump Media and Technology Group Corp. (Nasdaq, NYSE Texas: <a href="https://www.benzinga.com/stock/djt#Nasdaq,%20NYSE%20Texas">DJT</a>) ("Trump Media" or the "Company"), operator of the social media platform Truth Social, the streaming platform Truth+, and the FinTech brand Truth.Fi, announced today that it has filed a registration statement on form S-3 ("Registration Statement") with the U.S. Securities and Exchange Commission ("SEC") related to debt and equity subscription agreements recently entered into with approximately fifty investors that yielded approximately $2.3 billion in total proceeds—one of the largest Bitcoin treasury deals for a public company. The proceeds will be used for the Company's creation of a Bitcoin treasury and for general corporate purposes.
In accordance with registration obligations in the previously-disclosed agreements, the Registration Statement seeks to register for resale by the investors approximately 56 million shares of equity and 29 million shares underlying convertible notes.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Trump Media Files SEC Registration Statement To Enable Resale Of Shares From $2.3B Bitcoin-Focused Financing Deal With 50 Investors

Combination will fast-track Genpact's expansion of advanced technology solutions, amplifying data and AI capabilities, domain expertise, and strategic partnerships&nbsp;&nbsp;
NEW YORK, June 5, 2025 /PRNewswire/ --&nbsp;Genpact (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/G#NYSE">G</a>), a global advanced technology services and solutions company, today announced it has acquired XponentL Data, a data products and artificial intelligence (AI) solutions provider. XponentL brings differentiated domain-led data strategy, design, and engineering capabilities; deep industry experience; and strategic partnerships. This acquisition builds on Genpact's pivot to data, AI, and other advanced technologies, further enhancing Genpact's ability to help clients across the lifecycle of AI transformation, from strategy through implementation.

Genpact Acquires XponentL Data; Financial Details Of The Transaction Were Not Disclosed.

Management

NAVI

Navient Elects Edward Bramson Chair Of The Board Of Directors

IAC Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IAC#NASDAQ">IAC</a>) ("IAC") announced today that its wholly owned subsidiary, Dotdash Meredith Inc. ("DDM"), has agreed to sell $400 million aggregate principal amount of 7.625% senior secured notes due 2032 (the "Notes") in a private offering (the "Offering").&nbsp; The Notes will bear interest at an interest rate of 7.625% per annum and will be issued at 100.00% of their face value.&nbsp; DDM's obligations under the Notes will be guaranteed on a senior secured basis by certain of DDM's subsidiaries.
DDM intends to use the proceeds of the offering, together with the borrowings under DDM's new $700.0 million term loan B facility and cash on hand, to repay all of the indebtedness outstanding under DDM's existing $1.18 billion term loan B-1 facility and to pay related fees and expenses.&nbsp; The closings of each of the Offering and new term loan B facility are expected to occur on or about June 16, 2025, each subject to the satisfaction of customary closing conditions.

IAC's Dotdash Meredith, Has Agreed To Sell $400M Aggregate Principal Amount Of 7.625% Senior Secured Notes Due 2032

Air T, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIRT#NASDAQ">AIRT</a>) announced on June 2nd the successful renegotiation of a key financing agreement involving its wholly owned subsidiary, AAM 24-1, LLC.
The updated agreement, reached with the Company's existing institutional investors, grows the transaction from $30,000,000 to $100,000,000, extends repayment timelines and increases financial flexibility. These changes support Air T's long-term capital foundation while maintaining alignment with its strategic objectives and commitment to growth.

Financing

AIRT

Air T Expands Key Financing Deal From $30M To $100M, Boosting Flexibility And Supporting Long-Term Growth Strategy

<h3>Gainers</h3>
<ul>
<li>Jiade (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JDZG#NASDAQ">JDZG</a>) shares moved upwards by 10.5% to $0.38 during Thursday's after-market session. The company's market cap stands at $9.2 million. </li>
<li>Rent the Runway (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RENT#NASDAQ">RENT</a>) stock increased by 10.15% to $7.7. The market value of their outstanding shares is at $30.9 million. As per the news, the Q1 earnings report came out today. </li>
<li>Yunji (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YJ#NASDAQ">YJ</a>) stock moved upwards by 7.85% to $2.06. The market value of their outstanding shares is at $40.5 million. </li>
<li>NWTN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NWTN#NASDAQ">NWTN</a>) stock rose 6.17% to $1.72. The company's market cap stands at $492.2 million. </li>
<li>E-Home Household Service (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EJH#NASDAQ">EJH</a>) shares increased by 5.94% to $2.85. </li>
<li>Jianzhi Education Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JZ#NASDAQ">JZ</a>) shares rose 5.55% to $0.38. The company's market cap stands at $10.7 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Lululemon Athletica (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LULU#NASDAQ">LULU</a>) stock decreased by 22.9% to $255.09 during Thursday's after-market session. The company's market cap stands at $31.9 billion. As per the news, the Q1 earnings report came out today. </li>
<li>Golden Heaven Group Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDHG#NASDAQ">GDHG</a>) shares declined by 13.73% to $1.32. The market value of their outstanding shares is at $21.6 million. </li>
<li>Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) shares decreased by 11.88% to $3.19. The market value of their outstanding shares is at $889.9 million. As per the news, the Q1 earnings report came out today. </li>
<li>Top Win International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SORA#NASDAQ">SORA</a>) stock decreased by 9.42% to $6.35. The market value of their outstanding shares is at $157.8 million. </li>
<li>Zumiez (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZUMZ#NASDAQ">ZUMZ</a>) shares decreased by 6.3% to $12.05. The company's market cap stands at $230.8 million. As per the news, the Q1 earnings report came out today. </li>
<li>Genius Group (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/GNS#AMEX">GNS</a>) shares fell 5.53% to $0.34. The market value of their outstanding shares is at $24.3 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

GDHG

JDZG

LULU

NWTN

RENT

SORA

ZUMZ

12 Consumer Discretionary Stocks Moving In Thursday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Bluejay Diagnostics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BJDX#NASDAQ">BJDX</a>) stock rose 41.5% to $2.15 during Thursday's after-market session. The market value of their outstanding shares is at $3.2 million. </li>
<li>GlycoMimetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLYC#NASDAQ">GLYC</a>) shares moved upwards by 30.86% to $0.26. The company's market cap stands at $16.7 million. </li>
<li>Eyenovia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EYEN#NASDAQ">EYEN</a>) shares increased by 28.97% to $4.05. The company's market cap stands at $11.6 million. </li>
<li>Pediatrix Medical Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MD#NYSE">MD</a>) shares moved upwards by 8.47% to $15.1. The company's market cap stands at $1.2 billion. </li>
<li>Rani Therapeutics Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RANI#NASDAQ">RANI</a>) shares increased by 7.27% to $0.57. The company's market cap stands at $19.0 million. </li>
<li>RAPT Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RAPT#NASDAQ">RAPT</a>) stock rose 6.86% to $1.09. The company's market cap stands at $144.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Liminatus Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIMN#NASDAQ">LIMN</a>) shares declined by 18.7% to $20.0 during Thursday's after-market session. The company's market cap stands at $534.2 million. </li>
<li>Senti Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNTI#NASDAQ">SNTI</a>) shares decreased by 10.12% to $3.2. The market value of their outstanding shares is at $83.4 million. </li>
<li>Pheton Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTHL#NASDAQ">PTHL</a>) shares decreased by 9.44% to $8.06. The market value of their outstanding shares is at $116.8 million. </li>
<li>Universe Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPC#NASDAQ">UPC</a>) stock fell 8.15% to $3.86. The company's market cap stands at $58.7 million. </li>
<li>NewGenIvf Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NIVF#NASDAQ">NIVF</a>) shares decreased by 7.83% to $2.12. The market value of their outstanding shares is at $1.5 million. </li>
<li>Scinai Immunotherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCNI#NASDAQ">SCNI</a>) shares declined by 7.7% to $3.0. The company's market cap stands at $2.8 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BJDX

EYEN

GLYC

LIMN

NIVF

PTHL

RAPT

SCNI

SNTI

12 Health Care Stocks Moving In Thursday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Momentus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNTS#NASDAQ">MNTS</a>) shares moved upwards by 14.1% to $1.86 during Thursday's after-market session. The company's market cap stands at $10.2 million. </li>
<li>Virgin Galactic Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPCE#NYSE">SPCE</a>) shares increased by 11.5% to $3.49. The company's market cap stands at $145.0 million. </li>
<li>EuroDry (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EDRY#NASDAQ">EDRY</a>) shares moved upwards by 8.33% to $8.84. The market value of their outstanding shares is at $24.9 million. The company's, Q1 earnings came out today. </li>
<li>Quanex Building Prods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NX#NYSE">NX</a>) stock moved upwards by 7.19% to $18.32. The company's market cap stands at $865.2 million. The company's, Q2 earnings came out today. </li>
<li>Founder Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FGL#NASDAQ">FGL</a>) stock increased by 7.12% to $1.03. The company's market cap stands at $19.9 million. </li>
<li>Sidus Space (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIDU#NASDAQ">SIDU</a>) stock rose 6.44% to $1.57. The market value of their outstanding shares is at $28.7 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Concrete Pumping Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BBCP#NASDAQ">BBCP</a>) stock decreased by 12.3% to $6.2 during Thursday's after-market session. The company's market cap stands at $328.9 million. The company's, Q2 earnings came out today. </li>
<li>iPower (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPW#NASDAQ">IPW</a>) shares declined by 11.96% to $0.5. The company's market cap stands at $15.6 million. </li>
<li>Linkers Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LNKS#NASDAQ">LNKS</a>) stock fell 6.89% to $0.59. The company's market cap stands at $7.9 million. </li>
<li>Lucas GC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGCL#NASDAQ">LGCL</a>) stock decreased by 6.72% to $0.58. The company's market cap stands at $46.4 million. </li>
<li>ATIF Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZBAI#NASDAQ">ZBAI</a>) shares fell 6.71% to $0.63. The market value of their outstanding shares is at $10.9 million. </li>
<li>LanzaTech Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LNZA#NASDAQ">LNZA</a>) stock decreased by 6.09% to $0.23. The company's market cap stands at $52.9 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BBCP

EDRY

LGCL

LNKS

LNZA

MNTS

SIDU

SPCE

ZBAI

12 Industrials Stocks Moving In Thursday's After-Market Session

Press Releases

Universal Display Corporation Announces the Appointment of New Board Member

Sangoma and Sphinx Medical Technologies Join Forces to Transform Healthcare Communication

Sangoma Announces Date of Second Quarter Fiscal 2025 Financial Results and Conference Call

Sangoma Introduces Sangoma GenAI Platform, Transforming Business Communications with AI-Powered Innovations

Sangoma Announces Second Quarter Fiscal 2025 Results

Sangoma Exceeds FY25 Debt Reduction Targets Ahead of Plan and Launches Normal Course Issuer Bid

Sangoma to Present at the Planet MicroCap Showcase Las Vegas April 23-24, 2025

Sangoma Announces Date of Third Quarter Fiscal 2025 Financial Results and Conference Call

Sangoma Announces Third Quarter Fiscal 2025 Results

Susan Leveritt and Karla Roarty of Sangoma Spotlighted on the 2025 Women of the Channel List

Comments

Sangoma Technologies

Noticias

Últimas noticias sobre Sangoma Technologies (NASDAQ:SANG) Bolsa

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL